Association between level of fecal calprotectin and progression of Crohn's Disease
Kennedy, Nicholas A.
JournalClinical Gastroenterology & Hepatology
RightsCC0 1.0 Universal
MetadataShow full item record
Mucosal healing is associated with improved outcomes in patients with Crohn’s disease (CD), but assessment typically requires ileocolonoscopy. Calprotectin can be measured in fecal samples to determine luminal disease activity in place of endoscopy—this measurement is an important component of the treat to target strategy. We investigated whether levels of fecal calprotectin associate with subsequent CD progression.
CitationKennedy N [et al]. Association between level of fecal calprotectin and progression of Crohn's Disease. Clinical Gastroenterology & Hepatology. 2019 Feb 14
NoteThis article is freely available via Open Access. Click on the Publisher URL to access.
The following license files are associated with this item: